Controlling the thickness of the atherosclerotic plaque by statin medication.
Atherosclerosis, a chronic inflammatory disorder of the arterial wall, is a complex process whose dynamics are affected by multiple factors. The disease control consists of restraining it by administering statins. Slowing down or halting the plaque growth depends on the patient age at which the stat...
Main Authors: | Dorota Formanowicz, Jacek B Krawczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0239953 |
Similar Items
-
Management of High-Risk Atherosclerotic Patients by Statins May Be Supported by Logistic Model of Intima-Media Thickening
by: Dorota Formanowicz, et al.
Published: (2021-06-01) -
Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
by: Lingmin Zhao, et al.
Published: (2023-12-01) -
Analysis of Serum Cholesterol, Statins and Atherosclerotic Plaque in Ruptured and Unruptured Intracranial Aneurysm
by: Leonardo Zumerkorn Pipek, et al.
Published: (2022-01-01) -
Intracranial Atherosclerotic Plaque Morphologic Pattern and Enhancement Change With High‐Intensity Statin Therapy
by: Sebastian Sanchez, et al.
Published: (2023-11-01) -
Angiogenesis in the atherosclerotic plaque
by: Caroline Camaré, et al.
Published: (2017-08-01)